^
Association details:
| Biomarker: | PIGF-L |
|---|---|
| Cancer: | Glioblastoma |
| Drug: | Eylea (aflibercept intravitreal) (VEGF-A inhibitor, PIGF inhibitor) |
| Direction: | Sensitive |
Evidence:
Source:
Title:
Myeloid biomarkers associated with glioblastoma response to anti-VEGF therapy with aflibercept
Excerpt:
Low levels of PlGF at baseline were associated with response (OR=0.15, 95% CI 0.02 to 0.97, p=0.046)…
DOI:
10.1158/1078-0432.CCR-11-0271
Trial ID:
